Answers are grounded in this paper and cite their sources.
Seven new antimycotics are presented that are at different points of development or approval. These substances are mainly first-in-class drugs. They are primarily developed for systemic administration. However, with the support of a pharmacist, the intravenous formulation may be used as eyedrops. In this short review, the activities of the substances against various fungal infections are described. After unsuccessful conventional therapy of fungal eye infections, one of these new substances might be suitable to cure the mycosis.
No takes yet. Share an insight, caveat, or question.
W. Behrens‐Baumann (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: